Trial Outcomes & Findings for Clinical Evaluation of the Performance of Bionet Sphygmomanometer Modules Based on Protocol Presented by the International Organization for Standardization (NCT NCT06609486)
NCT ID: NCT06609486
Last Updated: 2025-03-03
Results Overview
The blood pressure used for evaluation was measured four times by auscultation (first reference BP to fourth reference BP, R1 to R4) and three times by the test medical device (first test BP to third test BP, T1 to T3) alternately. A minimum interval of 1 min was allowed between each BP measurement. Three data pairs (mean value of R1, R2 \& T1 / R2, mean value of R3 \& T2 / R3, mean value of R4 \& T3) were obtained from one study subject. Criterion 1 is that for valid data pairs, the mean value of the difference between the test medical device and the auscultation method BP (test device BP - auscultation BP) should be 5 mmHg or less and the standard deviation (SD) should be 8 mmHg or less. Criterion 2 is that, for study subjects, the ISO 81060-2:2018 for presenting different SD thresholds depending on the mean value of the difference should be satisfied. When mean value of the difference is ±1.6, ±0.0 mmHg, the SD should be less than 6.76 and 6.95 mmHg, respectively.
COMPLETED
NA
86 participants
Right after the experiment
2025-03-03
Participant Flow
Recruitment is made through the recruitment notice for patients and their guardians who visit Hanyang University Hospital. Subjects who meet the criteria presented in ISO 81060-2:2018 Protocol 5.1 Subject requirements are recruited.
\[Selection Criteria\] - Subjects who have consented to participate in the clinical trial and voluntarily consented in writing - Subjects who meet the criteria presented in ISO 81060-2:2018 Protocol 5.1 Subject requirements \[Items excluded from clinical trials\] - Complete blood pressure range recruitment (Range complete) - Arrhythmia - Device failure - Cuff size unavailable - Poor quality of Korotkoff sounds - Observers disagreement - Other factors
Unit of analysis: Data pair
Participant milestones
| Measure |
Blood Pressure Measurement Group
In this study, the protocol applied to automatic electronic blood pressure system module BN1 for performance evaluation is ISO's proposed "ISO 81060-2:2018 Non-invasive sphygmomanometers- Part2: Clinical investment of internal automatic measurement type". The initial BP measurement is performed alternately, measuring the blood pressure by the measurer and the test device once each, and measuring blood pressure by the measurer four times by the observer and three times by the test device.
A total of 86 study subjects were enrolled. Three data pairs (mean value of R1, R2 \& T1 / R2, mean value of R3 \& T2 / R3, mean value of R4 \& T3) were obtained from one study subject, and a total of 258 data pairs were obtained. Among them, some data of three study subjects did not satisfy the conditions required by ISO 81060-2:2018, so one dropout data pair (total of three dropout data pairs) occurred. Therefore, 255 valid data pairs were obtained from 86 study subjects.
|
|---|---|
|
Overall Study
STARTED
|
86 258
|
|
Overall Study
COMPLETED
|
86 255
|
|
Overall Study
NOT COMPLETED
|
0 3
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Blood Pressure Measurement Group
n=86 Participants
In this study, the protocol applied to automatic electronic blood pressure system module BN1 for performance evaluation is ISO's proposed "ISO 81060-2:2018 Non-invasive sphygmomanometers- Part2: Clinical investment of internal automatic measurement type". The initial BP measurement is performed alternately, measuring the blood pressure by the measurer and the test device once each, and measuring blood pressure by the measurer four times by the observer and three times by the test device.
Blood pressure measurement group: In this study, the protocol applied to automatic electronic blood pressure system module BN1 for performance evaluation is ISO's proposed "ISO 81060-2:2018 Non-invasive sphygmomanometers- Part2: Clinical investment of internal automatic measurement type". The initial BP measurement is performed alternately, measuring the blood pressure by the measurer and the test device once each, and measuring blood pressure by the measurer four times by the observer and three times by the test device.
|
|---|---|
|
Age, Categorical
<=18 years
|
41 Participants
n=86 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
44 Participants
n=86 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=86 Participants
|
|
Age, Continuous
|
23 years
STANDARD_DEVIATION 18.65 • n=86 Participants
|
|
Sex: Female, Male
Female
|
37 Participants
n=86 Participants
|
|
Sex: Female, Male
Male
|
49 Participants
n=86 Participants
|
|
Region of Enrollment
South Korea
|
86 participants
n=86 Participants
|
PRIMARY outcome
Timeframe: Right after the experimentPopulation: A total of 86 study subjects were enrolled. Three data pairs (mean value of R1, R2 \& T1 / R2, mean value of R3 \& T2 / R3, mean value of R4 \& T3) were obtained from one study subject, and a total of 258 data pairs were obtained. Among them, some data of three study subjects did not satisfy the conditions required by ISO 81060-2:2018, so one dropout data pair (total of three dropout data pairs) occurred. Therefore, 255 valid data pairs were obtained from 86 study subjects.
The blood pressure used for evaluation was measured four times by auscultation (first reference BP to fourth reference BP, R1 to R4) and three times by the test medical device (first test BP to third test BP, T1 to T3) alternately. A minimum interval of 1 min was allowed between each BP measurement. Three data pairs (mean value of R1, R2 \& T1 / R2, mean value of R3 \& T2 / R3, mean value of R4 \& T3) were obtained from one study subject. Criterion 1 is that for valid data pairs, the mean value of the difference between the test medical device and the auscultation method BP (test device BP - auscultation BP) should be 5 mmHg or less and the standard deviation (SD) should be 8 mmHg or less. Criterion 2 is that, for study subjects, the ISO 81060-2:2018 for presenting different SD thresholds depending on the mean value of the difference should be satisfied. When mean value of the difference is ±1.6, ±0.0 mmHg, the SD should be less than 6.76 and 6.95 mmHg, respectively.
Outcome measures
| Measure |
Blood Pressure Measurement Group
n=255 Data pair
In this study, the protocol applied to automatic electronic blood pressure system module BN1 for performance evaluation is ISO's proposed "ISO 81060-2:2018 Non-invasive sphygmomanometers- Part2: Clinical investment of internal automatic measurement type". The initial BP measurement is performed alternately, measuring the blood pressure by the measurer and the test device once each, and measuring blood pressure by the measurer four times by the observer and three times by the test device.
A total of 86 study subjects were enrolled. Three data pairs (mean value of R1, R2 \& T1 / R2, mean value of R3 \& T2 / R3, mean value of R4 \& T3) were obtained from one study subject, and a total of 258 data pairs were obtained. Among them, some data of three study subjects did not satisfy the conditions required by ISO 81060-2:2018, so one dropout data pair (total of three dropout data pairs) occurred. Therefore, 255 valid data pairs were obtained from 86 study subjects.
|
|---|---|
|
Test Device's Blood Pressure of Resting Condition
Criterion 1 (SBP)
|
-1.55 mmHg
Standard Deviation 6.25
|
|
Test Device's Blood Pressure of Resting Condition
Criterion 1 (DBP)
|
-0.02 mmHg
Standard Deviation 6.61
|
|
Test Device's Blood Pressure of Resting Condition
Criterion 2 (SBP)
|
-1.6 mmHg
Standard Deviation 4.97
|
|
Test Device's Blood Pressure of Resting Condition
Criterion 2 (DBP)
|
-0.0 mmHg
Standard Deviation 5.82
|
Adverse Events
Blood Pressure Measurement Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Jongshill Lee, Ph.D.
Hanyang University Seoul Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place